Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
555 studies found for:    PAH
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Hormonal, Metabolic, and Signaling Interactions in PAH
Conditions: Idiopathic Pulmonary Arterial Hypertension;   Heritable Pulmonary Arterial Hypertension;   Scleroderma Associated Pulmonary Arterial Hypertension;   Appetite Suppressant Associate PAH
2 Completed Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Interventions: Drug: Nitric Oxide;   Other: Placebo
3 Active, not recruiting Training With Whole Body Vibration Device in Patients With PAH
Condition: Pulmonary Artery Hypertension
Intervention: Device: Exercise Group Galileo PAH
4 Active, not recruiting Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia
Conditions: Thalassemia Major;   Thalassemia Intermedia;   Pulmonary Arterial Hypertension
Intervention: Other: Physician standard-of-care according to ESC/ERS Guidelines
5 Completed BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Dietary Supplement: Beetroot juice
6 Active, not recruiting Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Condition: Pulmonary Arterial Hypertension
7 Completed PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: PSA-Activated PSA-PAH1
8 Active, not recruiting Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension
Condition: Life Change Events
Interventions: Procedure: Pulmonary Arterial Denervation (PADN);   Drug: Sildenafil;   Drug: Bosentan;   Drug: Prostacyclin
9 Terminated Obstructive Sleep Apnea in Pulmonary Arterial Hypertension (OSA in PAH)
Conditions: Pulmonary Arterial Hypertension;   Obstructive Sleep Apnea
10 Completed Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Other: Blood draw
11 Recruiting [18F]FES PET/CT in PAH
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: [18F] FES
12 Recruiting Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (ADEMPAS, BAY63-2521)
13 Recruiting Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH
Condition: Pulmonary Arterial Hypertension
Interventions: Procedure: Blood Sampling;   Other: Cardiac MRI
14 Completed
Has Results
FK506 (Tacrolimus) in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Placebo;   Drug: FK506 level < 2 ng/ml;   Drug: FK506 level 2-3 ng/ml;   Drug: FK506 level 3-5 ng/ml
15 Recruiting Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years
Condition: PAH
Intervention: Drug: oral treprostinil
16 Completed Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)
Condition: Pulmonary Arterial Hypertension
17 Terminated
Has Results
Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: treprostinil;   Device: Crono Five ambulatory pump
18 Enrolling by invitation Ventricular Reversed Remodeling After LTX in PAH Patients
Condition: Pulmonary Arterial Hypertension
19 Active, not recruiting Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Macitentan
20 Completed Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
Condition: Hypertension, Pulmonary
Intervention: Drug: Assigned pulmonary hypertension medication

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years